One reason that depression is so difficult to treat is that it can have a wide range of causes. If, as in most cases, an anti-depressant is prescribed, it is hard to predict exactly how a patient’s condition will interact with the drug.
Recently Seroxat’s developers GlaxoSmithKline have received considerable bad publicity about the drug’s dangerous side effects. The evidence is mounting that it may not be suitable for treating children. Research has found that after taking Seroxat, children can experience an increase in suicidal thoughts.
There is a growing awareness that psychoactive treatments do not make the best default option for treating depression. Unfortunately they represent the easy option and of course make huge profits for the pharmaceutical industry.
> From The Guardian
> From The Observer